SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional,...
Imlunestrant was effective in combination with abemaciclib, and as monotherapy in ESR1-mutated breast cancer SAN ANTONIO – Imlunestrant, an investigational...
SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40...
SAN ANTONIO – Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have...
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Combination of radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, with much better survival rate rather than...
Insights may help uncover mechanisms and management strategies for human cancers PHILADELPHIA – Cancer prevalence rates varied widely across...
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its sincerest congratulations to the 14 AACR members who...
SAN ANTONIO – Laura J. van ’t Veer, PhD, will receive the William L. McGuire Memorial Lecture Award during...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award the 21st AACR-Irving Weinstein Foundation Distinguished Lectureship to...